German university research institute is looking for developer of anti-inflammation compounds targeting connexin hemichannels to test their cell and ex vivo tissue model

A German research institute wants to use its cell and ex vivo tissues as platform to test connexin (Cx) hemichannel inhibitors as drugs for the treatment of chronic inflammation-related diseases. Cxs form cell-to-cell channels between adjacent cells as well as hemichannels in single cells. Cx hemichannels are upregulated during inflammation and participate to further release of injury signals. The institute is looking for laboratories and companies to develop and test potential inhibitors.
Cooperación Tecnológica
Enlace: German university research institute is looking for developer of anti-inflammation compounds targeting connexin hemichannels to test their cell and ex vivo tissue model